发明名称 PYRIMIDINE COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide an IL-12 excessive production inhibitor. SOLUTION: This pyrimidine compound is expressed by formula (I) [wherein, R<SB>1</SB>is NC(R<SP>a</SP>)(R<SP>b</SP>), aryl or the like; R<SB>2</SB>, R<SB>4</SB>are each independently halogen, nitro, cyano, isothionitro or the like; R<SB>3</SB>is alkenyl, alkynyl or the like; R<SB>5</SB>is H or the like; (n) is 0 to 6; X is O, S, NR<SP>c</SP>or the like; Y is a covalent bond or the like; Z is N or CH; one of U and V is N and the other is CR<SP>c</SP>: and W is O, S, NR<SP>c</SP>or NC(O)R<SP>c</SP>]. This compound is useful for the treatment of chronic rheumatoid arthritis, septicemia, Crohn's disease, multiple sclerosis, psoriasis, insulin dependant diabetic mellitus or the like. COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2010248208(A) 申请公布日期 2010.11.04
申请号 JP20100130584 申请日期 2010.06.08
申请人 SYNTA PHARMACEUTICALS CORP 发明人 ONO MITSUNORI;SUN LIJUN;PRZEWLOKA TERESA;ZHANG SHIJIE;KOSTIK ELENA;YING WEIWEN;WADA YUMIKO;KOYA KEIZO;WU YAMING;ZHOU DAN;TATSUTA NORIAKI
分类号 C07D239/48;A61K31/506;A61K31/5377;A61K31/541;A61P1/00;A61P3/10;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P31/04;C07D401/12;C07D401/14;C07D403/12;C07D405/14 主分类号 C07D239/48
代理机构 代理人
主权项
地址